| 产品详情 |
| Edit |   |
| Product Name | Agomelatine |
| Description | Purity >98%. Melatonin, produced in the pineal gland, is an endogenous regulator of circadian rhythms. It acts through the melatonin receptors (MT1 and MT2) and has been shown to have anti-depressant activity in experimental models of clinical depression. Agomelatine is a metabolically stable analog of melatonin that displays agonist activity for MT1 and MT2 binding with nanomolar affinity. However, unlike melatonin, agomelatine is a competitive antagonist of human and porcine serotonin (5-HT2C ) receptors (pKi = 6.2 and 6.4, respectively) as well as human 5-HT2B receptors (pKi = 6.6). Agomelatine abolishes 5-HT2C agonist effects both in cells and in vivo . It also dose-dependently increases extracellular levels of noradrenaline and dopamine in frontal cortex of freely moving rats. |
| Size | n/a |
| Concentration | n/a |
| Applications | n/a |
| Other Names | N-[2-(7-methoxy-1-naphthalenyl)ethyl]-acetamide, Valdoxan® |
| Gene, Accession, CAS # | CAS: 138112-76-2 |
| Catalog # | LS-H6455 |
| Price | |
| Order / More Info | Agomelatine from LIFESPAN BIOSCIENCES INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|